Liminatus Pharma revenue was N/A for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LIMN annual revenue was $0.0, with N/A growth year-over-year.
LIMN revenue history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
Be the first to know when LIMN announces revenue.
LIMN Revenue History By Year
LIMN Yearly Revenue
LIMN Revenue
LIMN Change
LIMN Revenue Growth
2024-12-31
$0.00
N/A
N/A
2023-12-31
$0.00
N/A
N/A
2022-12-31
$0.00
N/A
N/A
1 of 1
Liminatus Pharma Revenue FAQ
What was LIMN's revenue last quarter?
Liminatus Pharma (NASDAQ: LIMN) reported Q2 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Liminatus Pharma's revenue was $0.00.
What was Liminatus Pharma's revenue in 2024?
Liminatus Pharma's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
How much does Liminatus Pharma make in a day?
Based on Liminatus Pharma annual revenue for the past two years, LIMN makes an average of $0.00 per day.
What was Liminatus Pharma's annual revenue growth in the past year?
As of Q4 2025, Liminatus Pharma's revenue has grown null year over year. Liminatus Pharma's revenue in the past year totaled N/A.
How much does Liminatus Pharma make in a year?
Liminatus Pharma's revenue by year for the past two years is:
Liminatus Pharma's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
Liminatus Pharma's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.